Hangzhou PhecdaMed Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Hangzhou PhecdaMed Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease (NCT07741045) | Hangzhou PhecdaMed Co., Ltd. | 2026-08-03 |
| Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia (NCT07620938) | Hangzhou PhecdaMed Co., Ltd. | 2026-06-12 |
| Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder (NCT07018245) | Hangzhou PhecdaMed Co., Ltd. | 2025-07-09 |
| Mass Balance Study of [14C] TJ0113 in Healthy Chinese Subjects (NCT06832540) | Hangzhou PhecdaMed Co., Ltd. | 2025-02-19 |
| Single Ascending Dose Study(SAD),Multiple Ascending Dose Study(MAD) , High-fat Diet Study (FE) of TJ0113 Capsules in Healthy Subjects (NCT07394452) | Hangzhou PhecdaMed Co., Ltd. | 2023-08-04 |
Track Hangzhou PhecdaMed Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.